Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain
- 1 October 2002
- journal article
- research article
- Published by Wolters Kluwer Health
- Vol. 99 (3) , 397-406
- https://doi.org/10.1016/s0304-3959(02)00102-1
Abstract
Pain is the cancer related event that is most disruptive to the cancer patient's quality of life. Although bone cancer pain is one of the most severe and common of the chronic pains that accompany breast, prostate and lung cancers, relatively little is known about the mechanisms that generatKeywords
This publication has 51 references indexed in Scilit:
- Mechanisms of neuropathic painBritish Journal of Anaesthesia, 2001
- The Effect of Site and Type of Nerve Injury on Spinal Glial Activation and Neuropathic Pain BehaviorExperimental Neurology, 1999
- Are there long-term changes in the basal or evoked Fos expression in the dorsal horn of the spinal cord of the mononeuropathic rat?Pain, 1999
- Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the ratJournal of Neuroimmunology, 1997
- Skeletal complications of malignancyCancer, 1997
- Inflammation Increases the Distribution of Dorsal Horn Neurons That Internalize the Neurokinin-1 Receptor in Response to Noxious and Non-Noxious StimulationJournal of Neuroscience, 1997
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994
- Is disease progression the major factor in morphine ‘tolerance’ in cancer pain treatment?PAIN®, 1993
- Lack of analgesic effect of opioids on neuropathic and idiopathic forms of painPain, 1988
- Substance P- and CGRP-immunoreactive nerves in bonePeptides, 1988